Nvidia leads market slump, erasing $278B from its market cap

), once a leader in chip stocks and tech rallies, has been hit by another sell-off on Tuesday, erasing $278 billion in market cap. Tuesday's sell-off was the worst single-day decline for a US company ever. The sell-off is continuing Wednesday morning as the tech sector -- The global peptide therapeutics market is estimated to thrive at a CAGR of 9.6% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for peptide therapeutics is estimated to reach US$ 85.

Vision Hospitality Group Highlights Multimillion-Dollar Renovation in Progress at Waterfront Celebration Hotel in Celebration, Florida, near Orlando CTLA4 Inhibitors - Global Strategic Business Report 2024-2030, with Coverage of Akeso, Alphamab Oncology, BioAtla, BioNTech, Sino Biological and Xencor

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

S&P/TSX composite down Tuesday, U.S. markets move higher ahead of Nvidia earningsTORONTO — Canada's main stock index moved lower on Tuesday, weighed down by energy stocks as oil prices retreated, while U.S. markets inched higher and the Dow added a few points to Monday's record high. U.S.
La source: SooToday - 🏆 8. / 85 Lire la suite »

Stocks open lower, Nvidia faces pressures ahead of earningsUS stocks (^DJI, ^IXIC, ^GSPC) open Tuesday lower as Nvidia (NVDA) shares dip ahead of the chipmaker's second quarter earnings report due out tomorrow...
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »

Nvidia reportedly targeted in antitrust probe: Yahoo FinanceUS markets (^DJI,^GSPC, ^IXIC) are off to a rocky start in September after posting their worst day since early August.Nvidia (NVDA) shares are under pressure...
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »